🔗 Read more: https://www.eortc.org/blog/2026/09/28/eortc-presents-new-results-at-eano/
EANO #EORTCbrain
🔗 Read more: https://www.eortc.org/blog/2026/09/28/eortc-presents-new-results-at-eano/
EANO #EORTCbrain
The #LUMEN1 trial protocol is out in @journalofnucmed.bsky.social.
This is the 1st randomised trial of [¹⁷⁷Lu]Lu-DOTATATE for recurrent #meningioma, exploring SSTR2-targeted therapy + advanced imaging, profiling & AI.
🔗 www.eortc.org/bibliography/
#EORTCBrain #NeuroOncology
The #LUMEN1 trial protocol is out in @journalofnucmed.bsky.social.
This is the 1st randomised trial of [¹⁷⁷Lu]Lu-DOTATATE for recurrent #meningioma, exploring SSTR2-targeted therapy + advanced imaging, profiling & AI.
🔗 www.eortc.org/bibliography/
#EORTCBrain #NeuroOncology
🔗 Read more: www.eortc.org/bibliography/
#NeuroOncology #Meningioma #EORTCbrain #CancerResearch
🔗 Read more: www.eortc.org/bibliography/
#NeuroOncology #Meningioma #EORTCbrain #CancerResearch
With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials.
🔗 Find out more: www.eortc.org/blog/2025/07...
#EORTCbrain #PETImaging
With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials.
🔗 Find out more: www.eortc.org/blog/2025/07...
#EORTCbrain #PETImaging